Fleming Pharmaceuticals Revenue and Competitors

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Fleming Pharmaceuticals's estimated annual revenue is currently $9.6M per year.(i)
  • Fleming Pharmaceuticals's estimated revenue per employee is $247,385

Employee Data

  • Fleming Pharmaceuticals has 39 Employees.(i)
  • Fleming Pharmaceuticals grew their employee count by -2% last year.

Fleming Pharmaceuticals's People

NameTitleEmail/Phone
1
Executive Administrative AssistantReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$2591.1M80577%N/AN/A
#2
$13.1M552%N/AN/A
#3
$9.6M38-5%N/AN/A
#4
$12.5M8261%N/AN/A
#5
$43.8M19911%N/AN/A
#6
$1.8M1864%N/AN/A
#7
$6.6M25-7%N/AN/A
#8
$11.7M5413%N/AN/A
#9
$1104.4M33693%$97MN/A
#10
$21.3M76-14%N/AN/A
Add Company

What Is Fleming Pharmaceuticals?

Specializing in the development and manufacture of innovative prescription and over-the-counter (OTC) therapies, privately held Fleming Pharmaceuticals is the proud maker of MAGONATE®, NEPHROCAPS®, NEPHROCAPS® QT, ThyroShield®, ProBarimin QT® and the OCEAN® Nasal Care line of products. Established in 1960, the company has developed products for a variety of clinical conditions in allergy, pediatrics, nephrology, nutrition, and obstetrics/gynecology. Based in the greater St. Louis area, our fully integrated headquarter facility houses state-of-the-art liquid and solid pharmaceutical manufacturing and packaging, analytical microbiological laboratories, research and development, distribution, marketing, and business administration functions.

keywords:N/A

N/A

Total Funding

39

Number of Employees

$9.6M

Revenue (est)

-2%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$8.9M390%N/A
#2
$35M39105%N/A
#3
$9.2M3918%N/A
#4
$8.2M410%N/A
#5
$4.6M418%N/A